Delta Sleep-Inducing Peptide
For educational and research reference only. Not medical advice. Not for human or animal use. Research peptides are Research Use Only (RUO).
Amino Acid Sequence
Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-GluAn interactive map of key discoveries, clinical trials, and major findings across 6 research milestones.
Schoenenberger and Monnier characterized a peptide isolated from rabbit cerebral venous blood. Synthetic DSIP infused into rabbit brain ventricles enhanced delta and spindle EEG patterns.
Timeline compiled from published research literature for educational reference. Dates reflect first major publication or event; subsequent research continues to refine findings.
DSIP is a small protein made of 9 amino acids that was originally discovered because of its apparent ability to promote a specific type of deep sleep called "delta sleep" (also known as slow-wave sleep). Think of it like a tiny molecular key that fits into certain locks in your brain to help regulate when and how you sleep. Scientists found it floating around in the blood and brain fluid of mammals, suggesting the body makes it naturally as part of its sleep system.
DSIP is hypothesized to modulate the activity of the hypothalamic-pituitary-adrenal (HPA) axis and interact with opioid, serotonergic, and GABAergic systems. It appears to influence the ratio of delta to sigma sleep stages, potentially through modulation of serotonin and GABA receptor signaling. Research suggests it may act as a "sleep-promoting factor" rather than a sedative — normalizing sleep architecture rather than forcing sedation.
Multiple human studies have been conducted with DSIP since the 1980s. Research in human subjects has explored its effects on sleep architecture, particularly delta (slow-wave) sleep patterns. Studies published in peer-reviewed journals have reported observations related to sleep quality and stress biomarkers in human volunteers. Clinical investigations have also examined DSIP in the context of chronic insomnia and disturbed sleep patterns, with researchers noting changes in sleep stage distribution.
Extensive animal research has been conducted, primarily in rabbits and rodents. The peptide was originally isolated from rabbit cerebral venous blood during electrically-induced sleep. Animal models have been used to study its effects on sleep-wake cycles, pain responses, stress hormones (particularly ACTH and cortisol), and body temperature regulation. Studies in rats have suggested potential interactions with the opioid system.
In vitro studies have examined DSIP's interactions with various receptor systems. Cell culture experiments have explored its effects on GABA receptors, serotonin pathways, and opioid binding sites. Laboratory research has also investigated its stability, degradation pathways, and the role of its phosphorylated form (P-DSIP).
DSIP stands for Delta Sleep-Inducing Peptide. It was named after its observed association with delta sleep waves (slow-wave sleep) when it was first discovered in 1977.
Yes. DSIP has been detected in human blood plasma and cerebrospinal fluid, suggesting it is endogenously produced. Its exact biosynthetic pathway is still being studied.
Delta sleep is the deepest stage of non-REM sleep, characterized by slow brain waves called delta waves. It is considered the most restorative phase of sleep and is when the body does most of its physical repair.
P-DSIP is the phosphorylated form of DSIP, where a phosphate group is attached to the serine residue. This modification may make the peptide more stable and potentially affects its biological activity.
No. DSIP is classified as a research peptide (Research Use Only — RUO). It is not approved as a drug, supplement, or therapeutic agent by any regulatory agency.
DSIP is relatively unstable in solution due to enzymatic degradation. The phosphorylated form (P-DSIP) may exhibit greater stability. Lyophilized (freeze-dried) form is recommended for storage. Should be stored at -20°C for long-term stability.
Research Use Only
For educational and research reference only. Not medical advice. Not for human or animal use. Research peptides are Research Use Only (RUO).